A randomized, open-label, phase 1 study to evaluate the effect of food on tivantinib (ARQ 197) pharmacokinetics

被引：0
|
作者：
Zahir, Hamim [1 ]
Oguma, Toshihiro [1 ]
Currie, Alexander [2 ]
Lee, Frank [3 ,4 ]
Walker, Joseph [1 ]
Tokui, Taro
机构：
[1] Daiichi Sankyo Pharma Dev, Edison, NJ USA
[2] Daiichi Sankyo Europe GmbH, Munich, Germany
[3] Celerion, Neptune, NJ USA
[4] Daiichi Sankyo Pharma Dev, Tokyo, Japan
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-755
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
755
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A Phase 1, Open-Label, Single-Dose Study to Evaluate Pharmacokinetics of MEDI0382 in Patients with Renal Impairment
    Klein, Gernot K.
    Petrone, Marcella
    Yang, Ye
    Hoang, Thuong
    Dicostanza, Sheila
    Hansen, Lars
    Flor, Armando
    DIABETES, 2019, 68
  • [32] AN OPEN-LABEL STUDY TO EVALUATE THE EFFECT OF OMEPRAZOLE ON THE PHARMACOKINETICS OF SOTORASIB (AMG 510) IN HEALTHY SUBJECTS.
    Cardona, P.
    Simiens, M.
    Purkis, J.
    Mather, O.
    Dutta, S.
    Houk, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S31 - S31
  • [33] An Open-Label, Phase 1 Study to Assess the Effects of Hepatic Impairment on Pomalidomide Pharmacokinetics
    Li, Yan
    Wang, Xiaomin
    Liu, Liangang
    Zhang, Chengyue
    Gomez, Diana
    Reyes, Josephine
    Palmisano, Maria
    Zhou, Simon
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (03): : 346 - 354
  • [34] Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study
    Sakurai, Yuuichi
    Shiino, Madoka
    Okamoto, Hiroyuki
    Nishimura, Akira
    Nakamura, Koki
    Hasegawa, Setsuo
    ADVANCES IN THERAPY, 2016, 33 (09) : 1519 - 1535
  • [35] Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency
    Bokemeyer, Bernd
    Krummenerl, Annette
    Maaser, Christian
    Howaldt, Stefanie
    Mross, Michael
    Mallard, Nick
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2017, 42 (02) : 229 - 238
  • [36] Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study
    Yuuichi Sakurai
    Madoka Shiino
    Hiroyuki Okamoto
    Akira Nishimura
    Koki Nakamura
    Setsuo Hasegawa
    Advances in Therapy, 2016, 33 : 1519 - 1535
  • [37] Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency
    Bernd Bokemeyer
    Annette Krummenerl
    Christian Maaser
    Stefanie Howaldt
    Michael Mroß
    Nick Mallard
    European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 229 - 238
  • [38] A Phase I, Randomized, Crossover, Open-label Study of the Pharmacokinetics of Solriamfetol (JZP-110) in Healthy Adult Subjects With and Without Food
    Zomorodi, Katie
    Kankam, Martin
    Lu, Yuan
    CLINICAL THERAPEUTICS, 2019, 41 (02) : 196 - 204
  • [39] A RANDOMIZED, OPEN-LABEL, CROSSOVER STUDY TO EVALUATE THE RELATIVE ORAL BIOAVAILABILITY OF 2 FORMULATIONS OF SEPIAPTERIN AND PALATABILITY AND THE FOOD EFFECT ON THE PHASE 3 FORMULATION IN HEALTHY SUBJECTS
    Gao, Lan
    Xia, Yi
    Ingalls, Kimberly
    Kaushik, Diksha
    Greenbaum, Rochelle
    Milner, Sarah
    Kong, Ron
    Smith, Neil
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (03) : 49 - 49
  • [40] Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer
    Tolaney, Sara M.
    Tan, Sally
    Guo, Hao
    Barry, William
    Van Allen, Eliezer
    Wagle, Nikhil
    Brock, Jane
    Larrabee, Katherine
    Paweletz, Cloud
    Ivanova, Elena
    Janne, Pasi
    Overmoyer, Beth
    Wright, John J.
    Shapiro, Geoffrey I.
    Winer, Eric P.
    Krop, Ian E.
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (05) : 1108 - 1114
12345